FAKTOR-OPTIONSSCHEIN - INCYTE CO. Stock

DE000SD416U2

Real-time Boerse Frankfurt Warrants 06:07:36 2024-05-27 EDT
8.23 ^EUR	-1.08%

Current month	-30.84%
1 month	-31.64%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	05-23	MT
Incyte Acquires 2 Office Buildings in Delaware	05-21	MT
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	05-21	BU
Incyte to Present at Upcoming Investor Conference	05-21	BU

More news

Quotes 5-day view

Date	Price	Change
24-05-27	8.23	-1.08%
24-05-24	8.32	+0.85%
24-05-23	8.25	+2.87%
24-05-22	8.02	-3.37%
24-05-21	8.3	-1.31%

Real-time Boerse Frankfurt Warrants

Last update May 27, 2024 at 06:07 am

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Société Générale
WKN	SD416U
ISIN	DE000SD416U2
Date issued	2021-03-29
Strike	79.94 $
Maturity	Unlimited
Parity	1 : 1
Emission price	8.48 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	14.62 €
Lowest since issue	3.34 €
Spread	0.38 €
Spread %	4.41%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.31 USD

Average target price

72.8 USD

Spread / Average Target

+27.03%

Consensus